Skip to main content

Mycapssa Prices, Coupons and Patient Assistance Programs

Mycapssa (octreotide) is a member of the somatostatin and somatostatin analogs drug class and is commonly used for Acromegaly.

The cost for Mycapssa oral delayed release capsule 20 mg is around $3,117 for a supply of 28 capsules, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Mycapssa is available as a brand name drug only, a generic version is not yet available. View generic Mycapssa availability for more details.

Mycapssa prices

Oral Delayed Release Capsule

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Mycapssa Coupons, Copay Cards and Rebates

Mycapssa offers may be in the form of a printable coupon, rebate, savings or copay card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Mycapssa CAPS Program: Eligible commercially insured patients may pay as little as $0 per fill; for additional information contact the program at 833-346-2277.

Applies to:
Mycapssa
Number of uses:
Per prescription until program expires

Form more information phone: 833-346-2277 or Visit website

Patient Assistance & Copay Programs for Mycapssa

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines and copay programs to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Mycapssa (octreotide) Capsule; Delayed Release

More information please phone: 866-316-7263 Visit Website

Provider: Amryt Assist Mycapssa Patient Support

Elligibility requirements:
  1. Determined case by case
  2. Determined case by case
  3. FDA-approved diagnosis
  4. Must be a US resident and treated by a US licensed healthcare provider
  5. Co-payment assistance, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Mycapssa (octreotide) Capsule; Delayed Release

More information please phone: 833-346-2277 Visit Website